By Ross Todd | November 6, 2018
Partin filled a crucial role in Roche's December 2017 tender offer to acquire biotech Ignyta Inc. for $1.7 billion.
By Ross Todd | October 30, 2018
Three former Genentech employees have been indicted for funneling trade secrets to biosimilar rival JHL Biotech. In a civil suit, Genentech is suing the employees, JHL, and its founders, who are both former Genentech employees themselves.
By Jenna Greene | May 2, 2018
Fish & Richardson partner Juanita Brooks, a titan of the IP bar, has been practicing for 40 years. This is the first time she's had a case where both her courtroom team and the in-house lawyers have all been women.
By Q. Todd Dickinson and Fabio Marino | April 30, 2018
In the most anticipated patent case of the year, the Supreme Court recently upheld the CAFC in Oil States Energy Services v. Greenes's Energy Group, supporting Congress' power to institute inter partes reviews (IPRs) in the American Invents Act's (AIA) post-grant review process.
By Sue Reisinger | March 6, 2018
The memo referred to a recent Supreme Court ruling in "Digital Realty Trust v. Somers."
By Ross Todd | February 14, 2018
According to the complaint, the former BD employees had access to "technical specifications, source code, and designs," and then downloaded thousands of confidential files prior to leaving the company.
By Scott Graham | February 6, 2018
In an appellate showdown between Fish & Richardson's Juanita Brooks and MoloLamken's Jeffrey Lamken, a Federal Circuit panel seemed swayed by Merck's argument that one bad witness didn't taint the jury's verdict.
By Ross Todd | January 23, 2018
Lawyers for Illumina Inc. and Ariosa Diagnostics—rivals in the burgeoning market for non-invasive prenatal testing (NIPT)—both asked a San Francisco federal jury for damage awards of around $100 million.
By Ross Todd | January 8, 2018
It's hard to imagine more divergent versions of the same business dispute than the ones laid out during opening arguments Monday by lawyers for Illumina Inc. and Ariosa Diagnostics—rivals in the burgeoning non-invasive prenatal testing (NIPT) industry.
By Scott Graham | January 4, 2018
Ariosa Diagnostics and Illumina Inc. are going to trial Monday in U.S. District Judge Susan Illston's San Francisco courtroom in a dispute over hundreds of millions of dollars and the IP used in non-invasive prenatal testing.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS